A vascular endothelial growth factor 121 (VEGF121)-based dual PET/optical probe for invivo imaging of VEGF receptor expression

Biomaterials

Volumn 34, Issue 28, 2013, Pages 6839-6845

  Kang, Choong Mo ^a,b   Koo, Hyun Jung ^a   Lee, Kyo Chul ^c   Choe, Yearn Seong ^a,b   Choi, Joon Young ^a   Lee, Kyung Han ^a,b   Kim, Byung Tae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

64Cu labeled dual probe; PET optical imaging; Streptavidin biotin platform; Tumor angiogenesis; VEGF121; VEGFR

Indexed keywords

FLUORESCENCE SIGNALS; HUMAN AORTIC ENDOTHELIAL CELLS; POSITRON EMISSION TOMOGRAPHY (PET); STREPTAVIDIN-BIOTIN PLATFORM; TUMOR ANGIOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF121; VEGFR;

COENZYMES; FLUORESCENCE; GEOMETRICAL OPTICS; HISTOLOGY; MAMMALS; OPTICAL IMAGE STORAGE; POSITRON EMISSION TOMOGRAPHY; PROTEINS; TUMORS;

PROBES;

BIOTIN; COPPER 64; STREPTAVIDIN; TETRAXETAN; VASCULOTROPIN 121; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RADIOCHEMISTRY;

ANIMALS; CELL LINE; CELL LINE, TUMOR; HUMANS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ALEXA; MUS;

EID: 84879464537     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.051     Document Type: Article

References (23)

1. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
2. Cherry S.R. Multimodality invivo imaging systems: twice the power or double the trouble?. Annu Rev Biomed Eng 2006, 8:35-62.
3. de Barros A.L.B., Tsourkas A., Saboury B., Cardoso V.N., Alavi A. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res 2012, 2:39.
4. Minchin R.F., Martin D.J. Minireview: nanoparticles for molecular imaging - an overview. Endocrinology 2010, 151:474-481.
5. Rosebrough S.F. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin. Nucl Med Biol 1993, 20:663-668.
6. 99mTc-HYNIC labeled avidin and streptavidin. Nucl Med Biol 2012, 39:1122-1127.
7. Green N.M. Avidin. Advances in protein chemistry 1975, 85-133. Academic Press, New York. C.B. Anfinsen, J.T. Edsall, F.M. Richard (Eds.).
8. 99mTc-hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to Cetuximab therapy. JNucl Med 2011, 52:1457-1464.
9. 121 for near-infrared fluorescence imaging of tumor angiogenesis. Mol Pharmaceut 2009, 6:285-294.
10. Liang M., Liu X., Cheng D., Liu G., Dou S., Wang Y., et al. Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Bioconjug Chem 2010, 21:1385-1388.
11. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006, 7:359-371.
12. Ferrara N., Hillan K.J., Gerber H.P., Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004, 3:391-400.
13. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004, 25:581-611.
14. Wang H., Cai W., Chen K., Li Z.B., Kashefi A., He L., et al. Anew PET tracer specific for vascular endothelial growth factor receptor 2. Eur J Nucl Med Mol Imaging 2007, 34:2001-2010.
15. Yoshimoto M., Kinuya S., Kawashima A., Nishii R., Yokoyama K., Kawai K. Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. Nucl Med Biol 2006, 33:963-969.
16. Cai W., Chen K., Mohamedali K.A., Cao Q., Gambhir S.S., Rosenblum M.G., et al. PET of vascular endothelial growth factor receptor expression. JNucl Med 2006, 47:2048-2056.
17. Rodriguez-Porcel M., Cai W., Gheysens O., Willmann J.K., Chen K., Wang H., et al. Imaging of VEGF receptor in a rat myocardial infarction model using PET. JNucl Med 2008, 49:667-673.
18. 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 2008, 117:915-922.
19. Cai W., Guzman R., Hsu A.R., Wang H., Chen K., Sun G., et al. Positron emission tomography imaging of poststroke angiogenesis. Stroke 2009, 40:270-277.
20. 121 for the imaging of VEGF receptor expression inU87MG tumor xenograft models. Eur J Nucl Med Mol Imaging 2013, 40:198-206.
21. Hnatowich D.J., Fritz B., Virzi F., Mardirossian G., Rusckowski M. Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nucl Med Biol 1993, 20:189-195.
22. Jung K.H., Park J.W., Paik J.Y., Lee E.J., Choe Y.S., Lee K.H. Hydrazinonicotinamide prolongs quantum dot circulation and reduces reticuloendothelial system clearance by suppressing opsonization and phagocyte engulfment. Nanotechnology 2012, 23:495102.
23. Clarke E.T., Martell A.E. Stabilities of the alkaline earth and divalent transition metal complexes of the tetraazamacrocyclic tetraacetic acid ligands. Inorg Chim Acta 1991, 190:27-36.